C07F3/003

NOVEL PROCESS FOR THE PREPARATION OF MACROCYCLIC CHELANT 2,2',2''-(10-(2-HYDROXYPROPYL)-1,4,7,10-TETRA AZACYCLODODECANE-1,4,7-TRIYL) TRIACETIC ACID AND IT'S COMPLEXES WITH PARAMAGNETIC METAL IONS
20210380542 · 2021-12-09 ·

The present invention relates to an improved process for the preparation of macrocyclic chelant 2,2′,2″-(10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetic acid of formula (1). The present invention further relates to the process for the preparation of metal complexes of macrocyclic chelant 2,2′,2″-(10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetic acid of formula (1) with purity greater than 99.0% by HPLC. The present invention also relates to an improved process for the preparation of gadolinium complex of formula (1a) with macrocyclic chelant 2,2′,2″-(10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetic acid of formula (1). The present invention further relates to a novel process for the preparation of calcium complex of formula (1b) with macrocyclic chelant 2,2′,2″-(10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetic acid of formula (1).

##STR00001##

PHARMACEUTICAL COMPOUNDS AND THERAPEUTIC METHODS

The invention provides a complex comprising Zn.sup.2+ and a compound of formula (I): or a deuterated analog thereof, or an ion or poly-ion thereof, or a salt thereof that is useful for treating cancer, as well as compositions and kits comprising such complexes.

##STR00001##

ZINC OXIDE COMPLEXES
20220162420 · 2022-05-26 ·

A complex formed by a zinc oxide molecule and a molecule comprising an acidic hydrogen is disclosed. The oxygen atom of the zinc oxide molecule is covalently bound to the acidic hydrogen.

CAPTURE OF MICROVESICLES FOR DIAGNOSTIC PURPOSES

The present invention relates to functionalized supports and their use in the diagnosis of pathologies.

Hydrated porous material and method for preparing same

A method of checking the storage and the radioactive activity of a radioactive gas adsorbed by a porous material having scintillation properties, which comprises: (a) putting the porous material in place in an enclosure, (b) performing circulation of the radioactive gas in the enclosure, (c) monitoring the adsorption of the radioactive gas by monitoring the scintillation of the porous material, up to an adsorption level, (d) interrupting the radioactive gas circulation in the enclosure when the adsorption level is attained, (e) placing the enclosure under a vacuum, and (f) monitoring the radioactive activity of the radioactive gas adsorbed by the porous material at the end of step (c) by monitoring the scintillation of the porous material. The porous material comprises metal organic frameworks formed of inorganic sub-units constituted by Zn.sub.4O and an organic ligand.

Metal-Organic Framework Materials Comprising A Diimine Scaffold and Methods For Production Thereof

Metal-organic framework materials (MOFs) are highly porous entities comprising a multidentate organic ligand coordinated to multiple metal centers, typically as a coordination polymer. Crystallization may be problematic in some instances when secondary binding sites are present in the multidentate organic ligand. Multidentate organic ligands comprising first and second binding sites bridged together with a third binding site comprising a diimine moiety may alleviate these issues, particularly when using a preformed metal cluster as a metal source to form a MOF. Such MOFs may comprise a plurality of metal centers, and a multidentate organic ligand coordinated to the plurality of metal centers to define an at least partially crystalline network structure having a plurality of internal pores, and in which the multidentate organic ligand comprises first and second binding sites bridged together with a third binding site comprising a diimine moiety. Particular MOFs may comprise N,N′-di(1H-pyrazol-4-yl)ethane-1,2-diimine as a multidentate organic ligand.

Metal complexes and methods of making the same

Disclosed herein are embodiments of metal complexes and methods of making the same. The disclosed method embodiments provide a one-step approach to making metal complexes, such as complexes comprising lanthanide metals, rare earth metals, transition metals, main group metals, and/or actinide metals that can be used various applications, such as in separations technology, catalysis (e.g., catalysts for pharmaceutical synthesis and/or catalysts for biomass conversion), nuclear chemistry, LED phosphors, scintillator materials, magnetic materials, and nuclear fuels.

MOLECULAR HYDROGEN ADSORBENT COMPRISING COPPER-BTC MOF

Mixed metal metal-organic frameworks (MM-MOFs) of copper-1,3,5-benzenetricarboxylate (BTC), M—Cu-BTC, wherein M is Zn(II), Ni(II), Co(II), and/or Fe(II) may be made using post-synthetic exchange (PSE) with metal ions. Such MM-MOFs may be used in H.sub.2 storage, especially Ni(II) and Co(II) MM-MOFs. Selected metal exchanged materials can provide gravimetric H.sub.2 uptake around 1.63 wt. % for Zn—Cu-BTC, around 1.61 wt. % for Ni—Cu-BTC, around 1.63 wt. % for Fe—Cu-BTC, and around 1.12 wt. % for Co—Cu-BTC.

Zinc oxide complexes
11725096 · 2023-08-15 · ·

A complex formed by a zinc oxide molecule and a molecule comprising an acidic hydrogen is disclosed. The oxygen atom of the zinc oxide molecule is covalently bound to the acidic hydrogen.

Freestanding metal-organic framework (MOF) aerogels and preparation

An aerogel is formed by preparing metal-organic framework (MOF) aerogels by preparing a porous solid comprising a metal precursor for the metal-organic framework (MOF) aerogels, and transforming the metal precursor into the MOF by reacting the porous solid with organic ligands mixed with a solvent. The solvent is then removed by supercritical extraction and drying.